BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1294057)

  • 1. Treatment of basal cell carcinoma with intralesional interferon alpha: a case report and literature review.
    McDonald RR; Georgouras K
    Australas J Dermatol; 1992; 33(2):81-6. PubMed ID: 1294057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of basal cell carcinoma with intralesional interferon.
    Vinciullo C
    Australas J Dermatol; 1993; 34(1):36. PubMed ID: 8240187
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of an intralesional sustained-release formulation of interferon alfa-2b on basal cell carcinomas.
    Edwards L; Tucker SB; Perednia D; Smiles KA; Taylor EL; Tanner DJ; Peets E
    Arch Dermatol; 1990 Aug; 126(8):1029-32. PubMed ID: 2383027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intralesional interferon alfa-2b in the treatment of basal cell carcinoma. Immunohistochemical study on cellular immune reaction leading to tumor regression.
    Buechner SA
    J Am Acad Dermatol; 1991 May; 24(5 Pt 1):731-4. PubMed ID: 1869644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of aggressive basal cell carcinoma with intralesional interferon: evaluation of efficacy by Mohs surgery.
    Stenquist B; Wennberg AM; Gisslén H; Larkö O
    J Am Acad Dermatol; 1992 Jul; 27(1):65-9. PubMed ID: 1619079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intralesional interferon-alpha 2b treatment of basal cell carcinoma.
    Thestrup-Pedersen K; Jacobsen IE; Frentz G
    Acta Derm Venereol; 1990; 70(6):512-4. PubMed ID: 1981427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of basal cell carcinoma with intralesional interferon alpha-2b.
    Healsmith MF; Berth-Jones J; Fletcher A; Graham-Brown RA
    J R Soc Med; 1991 Sep; 84(9):524-6. PubMed ID: 1941852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional interferon therapy for basal cell carcinoma.
    Cornell RC; Greenway HT; Tucker SB; Edwards L; Ashworth S; Vance JC; Tanner DJ; Taylor EL; Smiles KA; Peets EA
    J Am Acad Dermatol; 1990 Oct; 23(4 Pt 1):694-700. PubMed ID: 2229497
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intralesional interferon therapy for basal cell carcinoma.
    Epstein E
    J Am Acad Dermatol; 1992 Jan; 26(1):142-3. PubMed ID: 1732331
    [No Abstract]   [Full Text] [Related]  

  • 10. Basal cell carcinoma treated with interferon.
    Ikić D; Padovan I; Pipić N; Knezević M; Djaković N; Rode B; Kosutić I; Belicza M
    Int J Dermatol; 1991 Oct; 30(10):734-7. PubMed ID: 1955231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional and intralesional treatment of invasive basal cell carcinoma with interferon alfa-n2b.
    DiLorenzo PA; Goodman N; Lansville F; Markel W
    J Am Acad Dermatol; 1994 Jul; 31(1):109-11. PubMed ID: 8021351
    [No Abstract]   [Full Text] [Related]  

  • 12. Intralesional alpha 2b recombinant interferon for basal cell carcinomas.
    Boneschi V; Brambilla L; Chiappino G; Mozzanica N; Finzi AF
    Int J Dermatol; 1991 Mar; 30(3):220-4. PubMed ID: 2037410
    [No Abstract]   [Full Text] [Related]  

  • 13. Use of recombinant interferon alfa-2b in the treatment of basal cell carcinoma.
    Chimenti S; Peris K; Di Cristofaro S; Fargnoli MC; Torlone G
    Dermatology; 1995; 190(3):214-7. PubMed ID: 7599384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of basal cell carcinoma with intralesional interferon alpha-2a.
    LeGrice P; Baird E; Hodge L
    N Z Med J; 1995 May; 108(1000):206-7. PubMed ID: 7783992
    [No Abstract]   [Full Text] [Related]  

  • 15. Consideration of the cost of interferon alfa-2b in the treatment of basal cell carcinoma.
    Shiell A
    Australas J Dermatol; 1994; 35(2):71-5. PubMed ID: 7702490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intralesional alfa-2a interferon therapy for basal cell carcinoma.
    Doğan B; Harmanyeri Y; Baloğlu H; Oztek I
    Cancer Lett; 1995 May; 91(2):215-9. PubMed ID: 7767912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intralesional interferon gamma on basal cell carcinomas.
    Edwards L; Whiting D; Rogers D; Luck K; Smiles KA
    J Am Acad Dermatol; 1990 Mar; 22(3):496-500. PubMed ID: 2107219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistological evaluation of basal cell carcinoma immunoinfiltrate during intralesional treatment with alpha 2-interferon.
    Mozzanica N; Cattaneo A; Boneschi V; Brambilla L; Melotti E; Finzi AF
    Arch Dermatol Res; 1990; 282(5):311-7. PubMed ID: 2221983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of basal cell carcinoma with intralesional interferon.
    Georgouras K
    Australas J Dermatol; 1994; 35(1):47. PubMed ID: 7864996
    [No Abstract]   [Full Text] [Related]  

  • 20. Intralesional interferon alpha-2b in the treatment of basal cell carcinoma and squamous cell carcinoma: revisited.
    Kim KH; Yavel RM; Gross VL; Brody N
    Dermatol Surg; 2004 Jan; 30(1):116-20. PubMed ID: 14692941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.